Captive Care
Armenia and the Global Crisis of Healthcare Corruption
While disease outbreaks, ethnic conflict, and political instability often dominate headlines in frontier and emerging markets, a quieter, more corrosive threat undermines their long-term growth prospects: systemic healthcare corruption.
Globally, an estimated $455 billion is lost annually to healthcare corruption—roughly 6.2% of total health expenditures. In some frontier and emerging markets, losses reach up to 10–15% of national health budgets. Countries like Armenia illustrate the staggering cost of this dysfunction, revealing both human and economic consequences that demand a rethinking of traditional risk measurements.
The macroeconomic impacts of healthcare corruption in markets like Armenia culminate in significant operational and reputational risks, imperiling the profitability and long-term viability of local businesses. These risks manifest as increased workforce absenteeism, escalating employee healthcare costs, and a persistent struggle to attract and retain skilled professionals. This critical erosion of human capital is further fueled by medical exodus; a human tragedy where a compromised healthcare system forces individuals to abandon their homes and livelihoods for life-saving treatment, thereby directly undermining the nation’s productive capacity.
The Organization for Security and Co-operation in Europe (OSCE) warns that systemic corruption across post-Soviet states is weakening healthcare systems through fraudulent procurement, falsified licenses, and nepotistic hiring. In Armenia, these practices distort professional incentives, stifle innovation, and drive skilled practitioners out of the public health sector—weakening the very institutions meant to safeguard population wellbeing. As a result, public health is no longer merely a humanitarian concern but a strategic liability that compromises economic resilience and undermines investor confidence.
Armenian Healthcare Corruption
For decades, systemic corruption in Armenia has starved and damaged the country’s healthcare sector. Funds intended for staff development and new equipment have been siphoned off through procurement processes that divert funds into private hands, creating a hidden tax on public services and directly impacting the quality of care. Meritocratic processes have eroded medical education as well, where admissions, grading, and professional appointments have long been subject to bribery. Such practices have been further compounded by “nepotistic hiring and poor internal oversight that further displace qualified professionals, dismantling meritocracy." The systemic failures of the healthcare system create instability in the broader operating environment by reducing consumer expenditures, worsening health outcomes, driving medical exodus, and increasing skilled labor emigration.
The pervasive flow of unofficial fees and out-of-pocket payments places an immense financial burden on Armenian citizens. These payments accounted for 79 percent of current health expenditures in Armenia in 2022—a figure among the highest globally. As a direct consequence, one in five Armenians forgoes necessary care due to financial constraints. To put this in perspective, the World Health Organization (WHO) considers a population financially protected from health risks if up to 20% of overall healthcare expenses are paid by citizens out-of-pocket. Armenia's rate is approximately 2.7 times higher than the 2022 global average of approximately 30 percent for out-of-pocket expenses related to health.
Illicit practices in healthcare have resulted in critical staff shortages, the proliferation of counterfeit medications, untreated illnesses, and fatal delays in care as promising young doctors emigrate rather than accept low pay in a system that rewards connections over competence.
Paradoxically, these financial barriers are not the sole, or even primary, cause of mortality in countries like Armenia. Research published in The Lancet by Harvard’s Quest Center attributes a substantial share of preventable deaths not to financial constraints or limited access, but to poor quality of care. Even with the higher costs, noncommunicable diseases account for approximately 93 percent of Armenian mortality—a rate significantly above a global average of approximately 71 percent.
Some private clinics in Yerevan and other urban centers gleam with imported MRI scanners and architect-designed waiting rooms, but their appeal is primarily aesthetic. With fees rivaling those in Western Europe, these facilities remain out of reach for most Armenians. Even for those who can pay, the clinics rarely offer definitive treatment for cancer or other complex conditions. Oncology and dialysis slots are limited, specialists commute between multiple sites, and when stem cell therapy or advanced surgery is required, patients are routinely advised to seek care in Georgia, Israel, or France.
The gap between “shiny” infrastructure and real capability is most glaring in organ failure treatment. Despite formal legal approval in 2022, Armenia has still not carried out cadaveric (deceased donor) kidney, liver, or heart transplants in more than twenty-two years due to the non-functional national donor registry. Without that registry to match donors and recipients, set brain death protocols, and guarantee transparent allocation, the newest operating rooms sit idle when it matters most, and patients with end-stage organ disease reach a dead end.
All of these factors drain domestic capital expenditures and reveal a market failure where demand for critical services cannot be met locally—impacting the long-term viability of the consumer base and the broader investment climate.
A business owner who prefers to stay anonymous was forced to sell his assets and shutter his company to seek life-saving treatment abroad. “If I had stayed, grass would be growing on me.”
Illicit practices in healthcare have resulted in critical staff shortages, the proliferation of counterfeit medications, untreated illnesses, and fatal delays in care as promising young doctors emigrate rather than accept low pay in a system that rewards connections over competence. The consequences for the national economy have been stark: an unprepared, underpaid healthcare workforce incapable of providing adequate treatment has driven further medical exodus and wider emigration.
Patients often travel to access procedures that are otherwise unavailable to them or to seek better, more timely care. Manageable conditions, left untreated domestically, sometimes escalate into organ failure, forcing medical exodus. Patients with end-stage organ disease are almost always forced to seek treatment abroad at immense personal and financial cost. This medical exodus of Armenian patients seeking treatment abroad carries significant costs for the business community.
*One Armenian business owner was forced to sell his assets and shutter his company to seek life-saving treatment abroad. “If I had stayed, grass would be growing on me.” He would not have survived.
*Another medical refugee, an Armenian business owner and former construction manager, saw his life irrevocably shattered by chronic kidney failure. Following decades of hard work, he faced a healthcare system that was entirely incapable of meeting his needs for consistent, high-quality dialysis and long-term transplant care. His prognosis worsened amidst shortages of critical medications. Essential drugs for hemoglobin, potassium, and phosphate were unavailable or inconsistently supplied.
He recounted with frustration that no medication was ever provided to treat his low hemoglobin levels; instead, he was only offered blood transfusions. Worse, he learned some vital medicines were being siphoned off and sold 'under the table' by healthcare personnel at exorbitant prices. Yet even access to this illicit supply was not guaranteed. He came to believe that some patients were given this option only if they were seen as likely to complain or create problems, in an attempt by personnel to preempt scrutiny.
Trapped by a system demanding informal payments, lacking functional registries, and plagued by this illicit drug market, he faced an unconscionable choice. Fearing he would not survive in Armenia, his only option was to exhaust his family's entire life savings and abandon his home for treatment abroad.
These individuals are just small examples of a much larger phenomenon, with “Over 13,400 citizens of Armenia [having] requested asylum in Germany between 2015 and 2020,”; this number does not include the thousands more who flee to France and other nations to seek treatment.
*These personal accounts are based on direct conversations with affected individuals who requested anonymity due to the sensitive nature of their situations.
Those who engage in medical exodus subsequently encounter legal obstacles in Western countries that prevent them from participating in the workforce. Despite possessing valuable skills and a strong desire to contribute, many are denied opportunities to work or gain legal residency. Some apply for “sick foreigner residency” permits which are often denied, triggering costly legal expenses. Unable to work, some end up in homeless shelters, stranded abroad. Treated as economic burdens rather than individuals in need of protection, patients face deportation or arrest, even while in fragile health.
For the Armenian economy, these personal tragedies represent a direct loss of skilled labor, entrepreneurial energy, and consumer spending. Each medical exodus diminishes the available talent pool, reduces the domestic consumer base, and creates an unpredictable operating environment where key personnel or their family members may leave unexpectedly. This emigration represents a lost domestic healthcare market and a drain on national wealth, further diminishing the country’s investment attractiveness.
Healthcare Corruption as a Signal of Broader Institutional Weakness
Healthcare corruption is rarely isolated, and often signals deeper institutional weakness while further fueling the cycle itself. When a fundamental public service is compromised by bribery, nepotism, and diverted funds, it often reflects a broader erosion of rule of law, enforcement, and accountability. This undermines public trust not only in healthcare, but in governance and justice— foundations of a stable investment environment.
In 2024, Armenia’s net migration rate was approximately -5.2 per 1,000 people, following nearly a decade of consistent emigration.
The 2024 Bertelsmann Transformation Index notes that in Armenia, “officials aligned with the ruling government are rarely prosecuted,” and politically sensitive cases are often dropped. Transparency International’s Corruption Perceptions Index gave Armenia a score of 47/100 in 2024—consistent with the previous year and below the global average of 59 for public sector corruption. These indicators point to systemic governance risks that increase exposure for investors and reduce confidence in contract enforcement, regulatory consistency, and long-term planning. Businesses and investors operating there are forced to navigate unpredictable regulatory environments where unofficial payments may be expected for permits or licenses and opaque procurement processes leads to inflated costs and compromised quality.
The healthcare sector thus serves as a highly visible manifestation of this systemic failure, as seen through its exodus of doctors and the significant "brain drain" of skilled professionals to more stable countries. Armenia, like many post-Soviet states, faces substantial outward migration more broadly, directly impacting its economic potential and the availability of a stable workforce. In 2024, Armenia’s net migration rate was approximately -5.2 per 1,000 people, following nearly a decade of consistent emigration. This outflow, driven by factors such as job scarcity and unsatisfactory wages or career prospects, further diminishes the domestic consumer base and reduces the availability of skilled labor.
The Strategic Opportunity: Investing in Healthcare Integrity
While some business and investors should view these systemic failures as reasons to avoid investment altogether or to increase risk mitigation measures, others stand at a critical juncture due to their ability to lead the transformation of fragile healthcare systems into resilient foundations for growth. This is not merely a matter of corporate social responsibility - it is a matter of long-term strategic foresight, an investment in labor productivity, a more robust consumer base, and ultimately, sustainable market expansion.
By proactively addressing healthcare integrity, investors can unlock revenue streams, foster a healthier, more productive workforce, and support the foundational stability that undermines all economic prosperity.
Modern equipment alone cannot close this healthcare failing; only integrated governance, equitable financing, and data-driven allocation can turn sleek facilities into life-saving capacity. Opportunity lies in targeted investments that address the roots of corruption and inefficiency, offering a clear path to both social impact and financial return. These include:
Tapping Unmet Market Demand: Armenia’s current healthcare deficiencies represent substantial unmet demand for quality services. Private sector investment can fill these gaps, establishing market leadership and generating revenue from a population currently forced to seek care abroad. This includes specialized clinics, diagnostics, and advanced treatment facilities, creating a lucrative market for accessible, high-quality care.
Digital Transparency Solutions: A Lucrative Frontier for Investment. Investing in interoperable electronic medical records, national registries (such as a functioning deceased-donor organ transplant registry), and traceable procurement systems for medical equipment offers a compelling business case. These innovations reduce opportunities for corruption, improve efficiency, and generate verifiable health data that can enhance outcomes and reduce costs. The absence of a functional cadaveric transplant system in Armenia, with no deceased-donor organ transplants performed in over 20 years despite legal approval for a national donor registry in 2022, highlights a critical, solvable gap. This failure is not due to a lack of technical capabilities, but rather institutional failures. By providing infrastructure and services for these digital solutions, businesses can unlock new medical capabilities, build public trust, and establish high-value revenue streams. This is a first-mover opportunity in a nascent but essential digital health market.
Public-Private Partnerships (PPPs): Scalable Solutions for Shared Prosperity. These partnerships should not be viewed as charity but as scalable ventures that blend private innovation, capital, and accountability with public health goals. Proven models include the United States’ Organ Procurement and Transplantation Network (OPTN), operated by the nonprofit United Network for Organ Sharing (UNOS), and Canada’s Kidney Paired Donation Program managed by Canadian Blood Services. In India, private hospitals collaborate with government centers to supply transplant coordinators, raise awareness, and provide legal training. These models offer pathways for high-impact, high-return projects, often with government support or guaranteed patient flows, minimizing risks and maximizing long-term growth.
By proactively addressing healthcare integrity, investors can unlock revenue streams, foster a healthier, more productive workforce, and support the foundational stability that undermines all economic prosperity. For Western businesses, especially those with Armenian heritage, this is a unique opportunity to contribute to their homeland’s resilience while turning humanitarian concerns into strategic investments with lasting impacts.
The Bottom Line
In emerging and frontier markets, healthcare corruption directly erodes economic stability. For global businesses and investors, the impacts of healthcare corruption translate into operational and reputational risks that threaten profitability and long-term viability. Understanding the systemic issues associated with healthcare corruption is essential to ensuring robust due diligence and paving the way for sustainable returns.
Healthier societies support more stable and reliable consumer markets, fueling long-term demand and economic opportunity across sectors. By embracing healthcare investment as a pillar of market growth, the private sector can transform risk into resilience and deliver stronger societies and more sustainable markets for all.
Lastly, it’s important to remember that a robust, ethical healthcare system is not only an economic asset but also a fundamental assurance that individuals are not forced to compromise on their health, their livelihoods, and their communities. Healthcare investments can prove to be a profound commitment to our shared humanity.
Naira Philips is a global security and policy analyst with extensive experience working with U.S. government-funded organizations, including World Learning, the United States Institute of Peace, InterMedia, and many others. Her expertise spans media assessments, organizational effectiveness evaluations, anti-corruption legislative analysis, country risk assessments, illicit trade evaluations, policy analysis, and security risk assessments. She holds a Master’s in Security Studies from Georgetown University’s School of Foreign Service and a Master’s in International Relations and European Studies from Central European University.
The views and opinions expressed in this article are those of the author and do not reflect the official policy or position of any other organization or entity.
MonarchGSA is a strategic advisory firm built for startups, small and medium-sized enterprises (SMEs), and investors navigating global complexity. We combine elite expertise with practical insight to help you scale confidently and navigate volatile and high-risk environments.